High Flow Nasal Cannula Market's advanced Research & Growth Opportunities in Global Industry by 2022-2030 Edited by Leading Research Firm
FMI – an ESOMAR-certified market research firm, states that
the global high
flow nasal cannula market will reach US$ 17.7 Bn by 2030.
There has been a noteworthy increase in respiratory
disorders in the last few years. As per GBD (Global Burden of Diseases) study
2017, the cases pertaining to pneumoconiosis and COPD increased from 81.1% and
49.8% respectively from 1990 to 2017, and the number is expected to witness
exponentiation in the forecast period.
To remain ‘ahead’ of your competitors, request for
a Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-11269
Moreover, research states that high flow nasal cannula
oxygenation proves to be an effective mode of treatment for present day
Covid-19 caused by acute respiratory failure over non-invasive
positive pressure ventilation (NIPPV). As such, the global high flow nasal
cannula market is expected to witness traction in the short-term as well as in
the long run.
Key Takeaways of High Flow Nasal Cannula Market
Study
- Homecare
settings to hold the largest market share in 2020 due to outbreak of
Covid-19
- Sales
through e-commerce channels witnessing a spike, as end-users show a marked
preference for contactless delivery
- Single-use
high flow nasal cannulas to replace reusable nasal cannulas in the
forecast period due to increasing awareness regarding cross-contamination
High Flow Nasal Cannula Market: Competitive Landscape
The high flow nasal cannula market players are into the
expansion mode regarding their portfolio to have a competitive edge over one
another. They are also entering the inorganic growth mode to leave no stone
unturned regarding their presence in the market.
For instance –
- Hamilton
Medical AG, in Feb 2019, tabled “Nuflow single-use nasal cannulas” to
facilitate high flow oxygen therapy for neonates. One could find these
cannulas in 4 different sizes including a pair of fixation patches and an
adapter
- Teijin
holds the privilege of launching the first oxygen concentrator for Japan;
i.e. “Mildsanso”. As far as cardiovascular diseases are concerned,
Teijin’s Continuous Positive Airway Pressure (CPAP) devices holds over 40%
of the overall market for Japan.
- Salter
Labs have 15 LPM cannulas when there is more requirement of oxygen. ALOFT
cannulas are meant for extra comfort, especially for the geriatric
population
- OmniOx
from MEK-ICS Co., Ltd. Enables delivery of optimal humidification and has
an adjustable FiO2 with 21 ~ 100%
Smiths Medical has its pediatric divided CO2/O2 nasal
cannula, adult oral/nasal CO2, pediatric O2 nasal cannula under its CO2 sample
line
In Nov 2017, Teijin Pharma and SRETT agreed upon an
exclusive distribution arrangement all over Japan for “TeleOx”. This device
monitors respiratory functions in oxygen therapy. It is designed by SRETT
“CDC recommending HFNCO (High Flow Nasal Cannula Oxygenation)
for treating ARF (Acute Respiratory Failure) coupled with increase in
production capacity of high flow nasal cannulas to drive the market” says
the FMI analyst.
Want more insights?
High flow nasal cannula market, a new study from Future
Market Insights, states the indications of high flow nasal cannula from 2015 to
2019 and presents demand projections from 2020 from 2030 on the basis of
components (air/oxygen blender, active humidifier, nasal cannulas, heated
inspiratory circuit, and consumables), application (acute respiratory failure,
chronic obstructive pulmonary disease (COPD), bronchiectasis, carbon monoxide
toxicity, sleep apnea, acute heart failure, and others), and end user
(hospitals, specialty clinics, long-term care centers, ambulatory care centers,
and homecare setting) across seven prominent regions.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector
to identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and
consulting services, serving clients in over 150 countries. FMI is
headquartered in Dubai, and has delivery centers in the UK, U.S. and India.
FMI’s latest market research reports and industry analysis help
businesses navigate challenges and make critical decisions with confidence and
clarity amidst breakneck competition. Our customized and syndicated market
research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment